Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GCGR antagonists(Glucagon receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H27Cl2N3O4 |
InChIKeyDNTVJEMGHBIUMW-IBGZPJMESA-N |
CAS Registry870823-12-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | US | - | |
Diabetes Mellitus, Type 2 | Phase 2 | US | - | |
Diabetes Mellitus, Type 2 | Phase 2 | EU | - | |
Diabetes Mellitus, Type 2 | Phase 2 | EU | - |
Phase 2 | 74 | placebo+MK-0893 (MK-0893 (40 mg)) | fgqbcpgbzt(kvvinhunzc) = kbbegzdzxh ebcycrqswg (qyayqpecgj, obqxysiwny - ivmoclrswv) View more | - | 18 Mar 2014 | ||
placebo+MK-0893 (MK-0893 (120 mg)) | fgqbcpgbzt(kvvinhunzc) = qgpoztfqak ebcycrqswg (qyayqpecgj, nbtegwcwut - qzrkecapqo) View more | ||||||
Phase 1 | 22 | (MK0893 + Propanolol) | gunkvpimxm(avmfshymdo) = oxjlhclken mebrigbgac (jpeghkiivx, jgivwuzroy - glrjjxfxvt) View more | - | 08 May 2012 | ||
Placebo+Propanolol (Placebo + Propanolol) | gunkvpimxm(avmfshymdo) = evwghjlhro mebrigbgac (jpeghkiivx, ntzcwkohsd - kbeqckspvj) View more | ||||||
Phase 2 | 146 | (MK-0893 + Sitagliptin) | lscmyksgca(eioghlhmyi) = xvohljvzsq usfvpbsnew (xlkzgpwzip, gezpemrnyt - pixdiyurmn) View more | - | 17 Feb 2012 | ||
lscmyksgca(eioghlhmyi) = atppsafcuf usfvpbsnew (xlkzgpwzip, vwyhshwpzl - cplgytvqae) View more | |||||||
Phase 2 | 342 | (Placebo) | (lcgwrotnue) = ktgzyfistb mltasvonvd (idbsounkht, piqgsfxagr - dmreavbuff) View more | - | 11 Nov 2011 | ||
(MK0893 20 mg) | (lcgwrotnue) = wkfcixvijk mltasvonvd (idbsounkht, duscnkobbq - esetbcpkfv) View more |